🌟 Exploring the Future of Pharmaceutical Manufacturing with 3D Printing 🌟 Adare Pharma Solutions and Laxxon Medical are collaborating to explore the transformative potential of 3D printing in the pharmaceutical sector. This innovative partnership aims to revolutionize drug manufacturing by enabling customized solutions, reducing waste, and enhancing efficiency. As this partnership evolves, it could lead to more effective and accessible healthcare solutions. 🔗 Read more about this collaboration and its implications for the future of pharmaceutical manufacturing: https://lnkd.in/gN8HhMxx #Collaboration #PharmaceuticalManufacturing #3DPrinting #Innovation #Healthcare #PersonalizedMedicine Exentis Group AG Jared Matlis
Axendia, Inc.
市场调研
Yardley,PA 2,191 位关注者
Your Trusted Source of Exclusive Life Sciences Industry Insights and Advice since 2005
关于我们
Axendia is a leading analyst and strategic advisory firm that focuses exclusively on the Life Sciences markets. Since 2005, Industry stakeholders and regulators have relied on Axendia for trusted advice on Business, Regulatory and Technology issues and trends based on trusted sources. We provide strategic advice that enables our clients to prepare for, adapt to and overcome disruption. To this end, we conduct primary quantitative and qualitative research that our clients leverage to support their strategies and enables them to make informed decisions based on their unique needs. Axendia serves the entire Life Science ecosystem ranging from start-ups to Fortune 100 companies including: Life Science Organization, Technology & Service Providers, and Regulatory Agencies. Axendia professionals offer a unique combination of deep hands-on industry experience coupled with forward thinking insights. We contribute to our client’s success by providing long-range visibility and helping them navigate the increasingly complex landscape. To stay informed on the latest Industry trends, read Axendia’s Life Science Panorama, a Journal for Industry Executives, at: www.axendia.com/blog.
- 网站
-
https://www.axendia.com
Axendia, Inc.的外部链接
- 所属行业
- 市场调研
- 规模
- 2-10 人
- 总部
- Yardley,PA
- 类型
- 私人持股
- 创立
- 2005
- 领域
- Business、Technology、Regulatory、Human Factors、Industry Analyst、Pharmaceutical、Medical Device、Healthcare、Food、FDA、Ergonomics、Market Research、Life Sciences、Consulting和Advice
地点
-
主要
668 Stony Hill Road
Suite #316
US,PA,Yardley,19067
Axendia, Inc.员工
动态
-
🎉 Celebrating 19 Years of Axendia: A Journey of Trust & Innovation 🚀 -Daniel R. Matlis, President & Founder, Axendia, Inc. Nineteen years ago, we founded Axendia with a simple but powerful goal: to provide life sciences executives, technology companies, and regulators with strategic, actionable insights grounded in a deep understanding of our industry’s complexities. Since then, we've remained dedicated to that vision, consistently offering trusted advice that goes beyond buzzwords, trends, and jargon. We’re proud to have earned your trust along the way, becoming a valued partner in helping your organization navigate the intersection of business, technology, and regulatory domains. As we mark this milestone, it’s clear that the future is already taking shape, and we are privileged to be part of it. Technologies like artificial intelligence, machine learning, and quantum computing are transforming the life sciences landscape, and we remain committed to helping you integrate these advancements in ways that enhance decision-making and improve patient outcomes. However, none of this would have been possible without the trust and confidence of our clients, collaborators, and my fellow Axendians. You have been essential to our journey, and for that, we are deeply grateful. Your continued support has driven our growth and success, and we look forward to the opportunity to keep providing you with actionable insights. As we enter our 20th year, we are excited about what lies ahead. Together, we will continue shaping the future of life sciences, and for that, we are grateful. https://lnkd.in/e_5PnEM9 Sandra Rodriguez Daniel Matlis Kelly Doering Thomas Maeder Eric M. Luyer Ellyn McMullin Robyn Barnes Giselle C. Matlis Jared Matlis Jordan A. Matlis Mónica V. M. David Lennard
-
-
Great panel on “Strategies for Overcoming Digital Transformation Challenges in Life Sciences” moderated by our very own Daniel Matlis at #OperationsCalling. Valuable insights from: Christopher Kopinski Amazon Web Services (AWS) Patrick Hyett Plvs Ultra Dharmesh Ved MBA,BSEE,PMP,6 σ Black Belt,Lean Expert, ZS Grateful to Natan Linder Gilad Langer Phillip Chea Michelle Vuolo Madilynn Castillo Rony Kubat Martin BOISVERT Elise Jones Tulip Interfaces Mónica V. M. Sandra Rodriguez Kelly Doering
-
-
Tulip launches 𝘾𝙤𝙢𝙥𝙤𝙨𝙖𝙗𝙡𝙚 𝙈𝙀𝙎 𝙋𝙝𝙖𝙧𝙢𝙖 App Suite at #OperationsCalling. Natan Linder, CEO and Co-Founder Tulip Interfaces, took the stage to welcome attendees and emphasize that the future of frontline operations is composable. During his opening keynote, Natan announced the launch of cMES Pharma, Tulip's suite supporting Biopharma's needs. Stay tuned for our event brief for more on 𝘾𝙤𝙢𝙥𝙤𝙨𝙖𝙗𝙡𝙚 𝙈𝙀𝙎 𝙋𝙝𝙖𝙧𝙢𝙖. Gilad Langer Phillip Chea Michelle Vuolo Madilynn Castillo Rony Kubat Martin BOISVERT Elise Jones Jenna Gabriel Daniel Matlis Mónica V. M. Sandra Rodriguez Kelly Doering 4
-
-
Need to overcome digital transformation roadblocks in Life Sciences? Digital transformation in Life Sciences offers both rewards and challenges. With the right strategies, these challenges become opportunities for innovation and growth. Join our very own Daniel Matlis as he moderates dynamic discussion full of insights, practical advice, and success stories on achieving smooth digital transformation. Hear from industry leaders: • Christopher Kopinski from Amazon Web Services (AWS) • Patrick Hyett from Plvs Ultra • Dharmesh Ved MBA,BSEE,PMP,6 σ Black Belt,Lean Expert from ZS Let’s shape the future of Life Sciences together. #DigitalTransformation #LifeSciences #Compliance #Innovation #OperationsCalling #OpsCalling24 #OrganizationalChange #Governance Tulip Interfaces#Axendia
What makes digital transformation in Life Sciences more challenging than other industries? As opposed to organizations in less regulated sectors, in a Life Sciences context these initiatives place a greater emphasis on navigating the hurdles of validation, organizational change management, and governance. In this session, you'll gain insights and practical advice on avoiding these common stumbling blocks, as well as lessons learned for how to ensure a smooth digital transformation process. You'll hear from AWS's Christopher Kopinski, Plvs Ultra's Patrick Hyett, ZS's Dharmesh Ved, and Axendia's Daniel Matlis. See you next week at Operations Calling! #OperationsCalling #OpsCalling24
-
-
🧬 How Generative AI is Shaping the Future of Life Sciences 🚀 In our latest article, Sandra Rodriguez dives into the growing role of Generative AI in revolutionizing drug discovery, biological modeling, and patient data analysis. With so much potential, how can we ensure this technology is used responsibly? Enter the National Institute of Standards and Technology (NIST) #AI #RiskManagement Framework, designed to guide #LifeScience organizations in deploying AI in a safe, transparent, and ethical way. Discover how this framework is key to overcoming challenges like bias, transparency, and trust—while unlocking the full potential of #GenerativeAI in life sciences innovation. Read more here: https://lnkd.in/exBf7xf7 #GenerativeAI #LifeSciences #AI #Innovation #NISTFramework #DrugDiscovery #EthicalAI #MedTech #Pharma Mónica V. M. Daniel Matlis, Kelly Doering, Thomas Maeder, Robyn Barnes
Empowering Life Sciences: The Role of NIST’s AI Risk Management Framework to Drive Innovation
https://axendia.com
-
It’s a wrap! The MDIC APF Conference concluded with a meaningful FDA Townhall session featuring Douglas Kelly, MD, Keisha Thomas, and Daniel Caños expertly moderated by Jeff Shuren, CDRH Director Emeritus. A heartfelt thank you to all the speakers and participants for their insights. What a memorable and inspiring close to the event! Medical Device Innovation Consortium (MDIC) #APF2024 Joseph Sapiente Andrew Fish Matthew Victoria Colin Huband Steven Zera Daniel Matlis Sandra Rodriguez Kelly Doering Mónica V. M.
-
-
Started the day with insightful perspectives from FDA commissioner Robert Califf. Medical Device Innovation Consortium (MDIC) #APF2024 Matthew Victoria Colin Huband Andrew Fish Chip Hance Daniel Matlis Sandra Rodriguez Kelly Doering Mónica V. M.
-
-
✔️Advance patient safety ✔️Harmonize quality processes ✔️Drive operational excellence ✔️Run faster trials ✔️Achieve higher data accuracy ✔️Transform regulatory The #VeevaSummit covered all of these themes over the last two days in Boston with ~3000 of their customers partners and employees there to bear witness. it was a pleasure to be amongst the analysts and editors to cover this impressive event. Thank you to the Veeva Systems team for being such great hosts! Maria Scurry Deivis Mercado Mike Jovanis Mike Edwards Ashley McMillan Jamie Roberts Crouch Jason Boyd Justin Lavimodiere Kelly Doering Daniel Matlis Mónica V. M. Sandra Rodriguez
-
✔️Advance patient safety ✔️Harmonize quality processes ✔️Drive operational excellence ✔️Run faster trials ✔️Achieve higher data accuracy ✔️Transform regulatory The #VeevaSummit covered all of these themes over the last two days in Boston with ~3000 of their customers partners and employees there to bear witness. it was a pleasure to be amongst the analysts and editors to cover this impressive event. Thank you to the Veeva Systems team for being such great hosts! Maria Scurry Deivis Mercado Mike Jovanis Mike Edwards Ashley McMillan Jamie Roberts Crouch Jason Boyd Justin Lavimodiere Kelly Doering Daniel Matlis Mónica V. M. Sandra Rodriguez